{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:08:37Z","timestamp":1769602117406,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":219,"publisher":"Springer New York","isbn-type":[{"value":"9781493995530","type":"print"},{"value":"9781493995547","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9554-7_28","type":"book-chapter","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:39:21Z","timestamp":1562251161000},"page":"467-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Peripheral Biomarkers of Inflammation in Depression: Evidence from Animal Models and Clinical Studies"],"prefix":"10.1007","author":[{"given":"J. P.","family":"Br\u00e1s","sequence":"first","affiliation":[]},{"given":"S.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"M. I.","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"J.","family":"Prata","sequence":"additional","affiliation":[]},{"given":"O.","family":"von Doellinger","sequence":"additional","affiliation":[]},{"given":"R.","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"M. A.","family":"Barbosa","sequence":"additional","affiliation":[]},{"given":"S. G.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"28_CR1","volume-title":"Depression","author":"WHO","year":"2017","unstructured":"WHO (2017) Depression. WHO, Geneva"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jpsychores.2015.04.008","volume":"79","author":"R Abbott","year":"2015","unstructured":"Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C (2015) Tumour necrosis factor-alpha inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res 79:175\u2013184","journal-title":"J Psychosom Res"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.med.50.1.453","volume":"50","author":"E Frank","year":"1999","unstructured":"Frank E, Thase ME (1999) Natural history and preventative treatment of recurrent mood disorders. Annu Rev Med 50:453\u2013468","journal-title":"Annu Rev Med"},{"key":"28_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/581976","volume":"2015","author":"PW Gold","year":"2015","unstructured":"Gold PW, Machado-Vieira R, Pavlatou MG (2015) Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. Neural Plast 2015:581976","journal-title":"Neural Plast"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12020-014-0323-x","volume":"48","author":"V Fiore","year":"2015","unstructured":"Fiore V, Marci M, Poggi A, Giagulli VA, Licchelli B, Iacoviello M, Guastamacchia E, De Pergola G, Triggiani V (2015) The association between diabetes and depression: a very disabling condition. Endocrine 48:14\u201324","journal-title":"Endocrine"},{"key":"28_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/2047487318764158","volume":"25","author":"Y Wu","year":"2018","unstructured":"Wu Y, Sun D, Wang B, Li Y, Ma Y (2018) The relationship of depressive symptoms and functional and structural markers of subclinical atherosclerosis: a systematic review and meta-analysis. Eur J Prev Cardiol 25:706\u2013716","journal-title":"Eur J Prev Cardiol"},{"key":"28_CR7","volume-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"2013","unstructured":"APA (2013) Depressive disorders. In: Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/070674371506000104","volume":"60","author":"HE Pigott","year":"2015","unstructured":"Pigott HE (2015) The STAR\u2217D trial: it is time to reexamine the clinical beliefs that guide the treatment of major depression. Can J Psychiatry 60:9\u201313","journal-title":"Can J Psychiatry"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","volume":"41","author":"SM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41:326\u2013331","journal-title":"J Psychiatr Res"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S003329170500632X","volume":"36","author":"P Fitzgerald","year":"2006","unstructured":"Fitzgerald P, O\u2019Brien SM, Scully P, Rijkers K, Scott LV, Dinan TG (2006) Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med 36:37\u201343","journal-title":"Psychol Med"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66:407\u2013414","journal-title":"Biol Psychiatry"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370\u2013379","journal-title":"Neuropsychopharmacology"},{"key":"28_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000119332","volume":"35","author":"A Sluzewska","year":"1997","unstructured":"Sluzewska A, Sobieska M, Rybakowski JK (1997) Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 35:123\u2013127","journal-title":"Neuropsychobiology"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8\u201319","journal-title":"Arch Gen Psychiatry"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/0024-3205(89)90345-7","volume":"44","author":"R Dantzer","year":"1989","unstructured":"Dantzer R, Kelley KW (1989) Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 44:1995\u20132008","journal-title":"Life Sci"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12:123\u2013137","journal-title":"Neurosci Biobehav Rev"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","volume":"105","author":"SF Maier","year":"1998","unstructured":"Maier SF, Watkins LR (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105:83\u2013107","journal-title":"Psychol Rev"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298\u2013306","journal-title":"Med Hypotheses"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","volume":"84","author":"M Maes","year":"1991","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J (1991) Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84:379\u2013386","journal-title":"Acta Psychiatr Scand"},{"key":"28_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, de Jonckheere C, Minner B, Raus J (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22:45\u201353","journal-title":"Psychol Med"},{"key":"28_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","volume":"16","author":"M Maes","year":"1992","unstructured":"Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, Cooreman W, Vandervorst C, Raus J (1992) Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry 16:501\u2013515","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"28_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","volume":"14","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux F, Jung S (2014) Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 14:392\u2013404","journal-title":"Nat Rev Immunol"},{"key":"28_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953\u2013964","journal-title":"Nat Rev Immunol"},{"key":"28_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neuroscience.2015.01.001","volume":"289","author":"BF Reader","year":"2015","unstructured":"Reader BF, Jarrett BL, McKim DB, Wohleb ES, Godbout JP, Sheridan JF (2015) Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. Neuroscience 289:429\u2013442","journal-title":"Neuroscience"},{"key":"28_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","volume":"42","author":"SG Torres-Platas","year":"2014","unstructured":"Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N (2014) Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42:50\u201359","journal-title":"Brain Behav Immun"},{"key":"28_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","volume":"107","author":"KD Denicoff","year":"1987","unstructured":"Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA (1987) The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107:293\u2013300","journal-title":"Ann Intern Med"},{"key":"28_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24\u201331","journal-title":"Trends Immunol"},{"key":"28_CR29","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","volume":"18","author":"L Capuron","year":"2000","unstructured":"Capuron L, Ravaud A, Dantzer R (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy. J Clin Oncol 18:2143\u20132151","journal-title":"J Clin Oncol"},{"key":"28_CR30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4088\/JCP.v66n0814","volume":"66","author":"A Constant","year":"2005","unstructured":"Constant A, Castera L, Dantzer R, Couzigou P, de Ledinghen V, Demotes-Mainard J, Henry C (2005) Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic\/hypomanic and depressive symptoms. J Clin Psychiatry 66:1050\u20131057","journal-title":"J Clin Psychiatry"},{"key":"28_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7224\/1537-2073-14.1.10","volume":"14","author":"S Kim","year":"2012","unstructured":"Kim S, Foley FW, Picone MA, Halper J, Zemon V (2012) Depression Levels and Interferon Treatment in People with Multiple Sclerosis. Int J MS Care 14:10\u201316","journal-title":"Int J MS Care"},{"key":"28_CR32","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1038\/tp.2016.274","volume":"7","author":"WC Chiu","year":"2017","unstructured":"Chiu WC, Su YP, Su KP, Chen PC (2017) Recurrence of depressive disorders after interferon-induced depression. Transl Psychiatry 7:e1026","journal-title":"Transl Psychiatry"},{"key":"28_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.4088\/JCP.12r07694","volume":"73","author":"M Udina","year":"2012","unstructured":"Udina M, Castellvi P, Moreno-Espana J, Navines R, Valdes M, Forns X, Langohr K, Sola R, Vieta E, Martin-Santos R (2012) Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 73:1128\u20131138","journal-title":"J Clin Psychiatry"},{"key":"28_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep29920","volume":"6","author":"Y Murakami","year":"2016","unstructured":"Murakami Y, Ishibashi T, Tomita E, Imamura Y, Tashiro T, Watcharanurak K, Nishikawa M, Takahashi Y, Takakura Y, Mitani S, Fujigaki H, Ohta Y, Kubo H, Mamiya T, Nabeshima T, Kim H-C, Yamamoto Y, Saito K (2016) Depressive symptoms as a side effect of Interferon-\u03b1 therapy induced by induction of indoleamine 2,3-dioxygenase 1. Sci Rep 6:29920","journal-title":"Sci Rep"},{"key":"28_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","volume":"19","author":"CL Raison","year":"2005","unstructured":"Raison CL, Demetrashvili M, Capuron L, Miller AH (2005) Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19:105\u2013123","journal-title":"CNS Drugs"},{"key":"28_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0033-3182(95)71658-9","volume":"36","author":"AD Valentine","year":"1995","unstructured":"Valentine AD, Meyers CA (1995) Successful treatment of interferon-alpha-induced mood disorder with nortriptyline. Psychosomatics 36:418\u2013419","journal-title":"Psychosomatics"},{"key":"28_CR37","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJM200103293441303","volume":"344","author":"DL Musselman","year":"2001","unstructured":"Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961\u2013966","journal-title":"N Engl J Med"},{"key":"28_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gut.2007.131607","volume":"57","author":"MR Kraus","year":"2008","unstructured":"Kraus MR, Sch\u00e4fer A, Sch\u00f6ttker K, Keicher C, Weissbrich B, Hofbauer I, Scheurlen M (2008) Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 57:531","journal-title":"Gut"},{"key":"28_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/nedt.2006.2.3.355","volume":"2","author":"RK Gupta","year":"2006","unstructured":"Gupta RK, Kumar R, Bassett M (2006) Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments. Neuropsychiatr Dis Treat 2:355\u2013358","journal-title":"Neuropsychiatr Dis Treat"},{"key":"28_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0014-2999(98)00187-3","volume":"349","author":"O Morikawa","year":"1998","unstructured":"Morikawa O, Sakai N, Obara H, Saito N (1998) Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 349:317\u2013324","journal-title":"Eur J Pharmacol"},{"key":"28_CR41","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"CB Zhu","year":"2006","unstructured":"Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121\u20132131","journal-title":"Neuropsychopharmacology"},{"key":"28_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(94)90933-4","volume":"179","author":"WA Banks","year":"1994","unstructured":"Banks WA, Kastin AJ, Gutierrez EG (1994) Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 179:53\u201356","journal-title":"Neurosci Lett"},{"key":"28_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000097202","volume":"2","author":"WA Banks","year":"1995","unstructured":"Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2:241\u2013248","journal-title":"Neuroimmunomodulation"},{"key":"28_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","volume":"38","author":"R Yirmiya","year":"2015","unstructured":"Yirmiya R, Rimmerman N, Reshef R (2015) Depression as a microglial disease. Trends Neurosci 38:637\u2013658","journal-title":"Trends Neurosci"},{"key":"28_CR45","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314","journal-title":"Science"},{"key":"28_CR46","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456","journal-title":"Science"},{"key":"28_CR47","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164\u20131178","journal-title":"Cell"},{"key":"28_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fncel.2014.00229","volume":"8","author":"C Limatola","year":"2014","unstructured":"Limatola C, Ransohoff RM (2014) Modulating neurotoxicity through CX3CL1\/CX3CR1 signaling. Front Cell Neurosci 8:229","journal-title":"Front Cell Neurosci"},{"key":"28_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/glia.10259","volume":"43","author":"S Meeuwsen","year":"2003","unstructured":"Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM (2003) Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43:243\u2013253","journal-title":"Glia"},{"key":"28_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0006-8993(01)02766-4","volume":"914","author":"Y Pang","year":"2001","unstructured":"Pang Y, Cai Z, Rhodes PG (2001) Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res 914:15\u201322","journal-title":"Brain Res"},{"key":"28_CR51","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn.2887","volume":"14","author":"B Ajami","year":"2011","unstructured":"Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142\u20131149","journal-title":"Nat Neurosci"},{"key":"28_CR52","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","volume":"211","author":"R Yamasaki","year":"2014","unstructured":"Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, Kidd G, Zorlu MM, Sun N, Hu W, Liu L, Lee J-C, Taylor SE, Uehlein L, Dixon D, Gu J, Floruta CM, Zhu M, Charo IF, Weiner HL, Ransohoff RM (2014) Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 211:1533\u20131549","journal-title":"J Exp Med"},{"key":"28_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neuroscience.2014.10.004","volume":"302","author":"CM Sawicki","year":"2015","unstructured":"Sawicki CM, McKim DB, Wohleb ES, Jarrett BL, Reader BF, Norden DM, Godbout JP, Sheridan JF (2015) Social defeat promotes a reactive endothelium in a brain region-dependent manner with increased expression of key adhesion molecules, selectins and chemokines associated with the recruitment of myeloid cells to the brain. Neuroscience 302:151\u2013164","journal-title":"Neuroscience"},{"key":"28_CR54","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s11064-017-2270-4","volume":"42","author":"L Tong","year":"2017","unstructured":"Tong L, Gong Y, Wang P, Hu W, Wang J, Chen Z, Zhang W, Huang C (2017) Microglia loss contributes to the development of major depression induced by different types of chronic stresses. Neurochem Res 42:2698\u20132711","journal-title":"Neurochem Res"},{"key":"28_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028330","volume":"6","author":"JS Grigoleit","year":"2011","unstructured":"Grigoleit JS, Kullmann JS, Wolf OT, Hammes F, Wegner A, Jablonowski S, Engler H, Gizewski E, Oberbeck R, Schedlowski M (2011) Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PLoS One 6:e28330","journal-title":"PLoS One"},{"key":"28_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445\u2013452","journal-title":"Arch Gen Psychiatry"},{"key":"28_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","volume":"21","author":"MG Frank","year":"2007","unstructured":"Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF (2007) Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 21:47\u201359","journal-title":"Brain Behav Immun"},{"key":"28_CR58","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1523\/JNEUROSCI.0450-11.2011","volume":"31","author":"ES Wohleb","year":"2011","unstructured":"Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, Nelson RJ, Godbout JP, Sheridan JF (2011) beta-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci 31:6277\u20136288","journal-title":"J Neurosci"},{"key":"28_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbi.2009.07.008","volume":"24","author":"MG Frank","year":"2010","unstructured":"Frank MG, Miguel ZD, Watkins LR, Maier SF (2010) Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav Immun 24:19\u201330","journal-title":"Brain Behav Immun"},{"key":"28_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2007.01.039","volume":"1142","author":"M Leventopoulos","year":"2007","unstructured":"Leventopoulos M, Ruedi-Bettschen D, Knuesel I, Feldon J, Pryce CR, Opacka-Juffry J (2007) Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res 1142:119\u2013126","journal-title":"Brain Res"},{"key":"28_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mp.2014.21","volume":"20","author":"C Nagy","year":"2014","unstructured":"Nagy C, Suderman M, Yang J, Szyf M, Mechawar N, Ernst C, Turecki G (2014) Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol Psychiatry 20:320","journal-title":"Mol Psychiatry"},{"key":"28_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-013-1102-0","volume":"126","author":"RJ Tynan","year":"2013","unstructured":"Tynan RJ, Beynon SB, Hinwood M, Johnson SJ, Nilsson M, Woods JJ, Walker FR (2013) Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. Acta Neuropathol 126:75\u201391","journal-title":"Acta Neuropathol"},{"key":"28_CR63","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nn.4113","volume":"18","author":"GE Hodes","year":"2015","unstructured":"Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015) Neuroimmune mechanisms of depression. Nat Neurosci 18:1386\u20131393","journal-title":"Nat Neurosci"},{"key":"28_CR64","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","volume":"21","author":"MR Irwin","year":"2007","unstructured":"Irwin MR, Miller AH (2007) Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21:374\u2013383","journal-title":"Brain Behav Immun"},{"key":"28_CR65","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.psyneuen.2005.02.010","volume":"30","author":"HM Burke","year":"2005","unstructured":"Burke HM, Davis MC, Otte C, Mohr DC (2005) Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30:846\u2013856","journal-title":"Psychoneuroendocrinology"},{"key":"28_CR66","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0006-2952(02)01147-4","volume":"64","author":"A Amsterdam","year":"2002","unstructured":"Amsterdam A, Tajima K, Sasson R (2002) Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 64:843\u2013850","journal-title":"Biochem Pharmacol"},{"key":"28_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00726-011-1186-6","volume":"45","author":"F Marino","year":"2013","unstructured":"Marino F, Cosentino M (2013) Adrenergic modulation of immune cells: an update. Amino Acids 45:55\u201371","journal-title":"Amino Acids"},{"key":"28_CR68","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey KJ (2002) The inflammatory reflex. Nature 420:853\u2013859","journal-title":"Nature"},{"key":"28_CR69","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1073\/pnas.1118355109","volume":"109","author":"S Cohen","year":"2012","unstructured":"Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, Turner RB (2012) Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci 109:5995\u20135999","journal-title":"Proc Natl Acad Sci"},{"key":"28_CR70","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.biopsych.2008.05.018","volume":"64","author":"AH Miller","year":"2008","unstructured":"Miller AH (2008) Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point? Biol Psychiatry 64:263\u2013265","journal-title":"Biol Psychiatry"},{"key":"28_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.iac.2009.02.006","volume":"29","author":"R Avitsur","year":"2009","unstructured":"Avitsur R, Powell N, Padgett DA, Sheridan JF (2009) Social interactions, stress, and immunity. Immunol Allergy Clin North Am 29:285\u2013293","journal-title":"Immunol Allergy Clin North Am"},{"key":"28_CR72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.psyneuen.2007.10.007","volume":"33","author":"H Engler","year":"2008","unstructured":"Engler H, Bailey MT, Engler A, Stiner-Jones LM, Quan N, Sheridan JF (2008) Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen. Psychoneuroendocrinology 33:108\u2013117","journal-title":"Psychoneuroendocrinology"},{"key":"28_CR73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nri3660","volume":"14","author":"MG Manz","year":"2014","unstructured":"Manz MG, Boettcher S (2014) Emergency granulopoiesis. Nat Rev Immunol 14:302\u2013314","journal-title":"Nat Rev Immunol"},{"key":"28_CR74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1359786806066063","volume":"20","author":"CM Pariante","year":"2006","unstructured":"Pariante CM (2006) The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol 20:79\u201384","journal-title":"J Psychopharmacol"},{"key":"28_CR75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/nyas.12781","volume":"1351","author":"MA Horowitz","year":"2015","unstructured":"Horowitz MA, Zunszain PA (2015) Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin. Ann N Y Acad Sci 1351:68\u201379","journal-title":"Ann N Y Acad Sci"},{"key":"28_CR76","first-page":"56","volume":"47","author":"GF Oxenkrug","year":"2010","unstructured":"Oxenkrug GF (2010) Tryptophan\u2013kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci 47:56\u201363","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"28_CR77","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger JC, Lotrich FE (2013) Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246:199\u2013229","journal-title":"Neuroscience"},{"key":"28_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ddr.20013","volume":"65","author":"MW Walter","year":"2005","unstructured":"Walter MW (2005) Monoamine reuptake inhibitors: highlights of recent research developments. Drug Dev Res 65:97\u2013118","journal-title":"Drug Dev Res"},{"key":"28_CR79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1042\/bj3200595","volume":"320","author":"MP Heyes","year":"1996","unstructured":"Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP (1996) Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320:595\u2013597","journal-title":"Biochem J"},{"key":"28_CR80","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1742-2094-8-94","volume":"8","author":"J Steiner","year":"2011","unstructured":"Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, Meyer zu Schwabedissen L, Bogerts B, Myint AM (2011) Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8:94","journal-title":"J Neuroinflammation"},{"key":"28_CR81","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0891-5849(99)00272-5","volume":"28","author":"Y Dang","year":"2000","unstructured":"Dang Y, Dale WE, Brown OR (2000) Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway. Free Radic Biol Med 28:615\u2013624","journal-title":"Free Radic Biol Med"},{"key":"28_CR82","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007\u20132017","journal-title":"J Neurochem"},{"key":"28_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70:299\u2013307","journal-title":"J Neurochem"},{"key":"28_CR84","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1742-4658.2009.07487.x","volume":"277","author":"N Braidy","year":"2010","unstructured":"Braidy N, Grant R, Adams S, Guillemin GJ (2010) Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J 277:368\u2013382","journal-title":"FEBS J"},{"key":"28_CR85","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61:519\u2013525","journal-title":"Med Hypotheses"},{"key":"28_CR86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"98","author":"AM Myint","year":"2007","unstructured":"Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98:143\u2013151","journal-title":"J Affect Disord"},{"key":"28_CR87","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","volume":"9","author":"F Fallarino","year":"2002","unstructured":"Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9:1069\u20131077","journal-title":"Cell Death Differ"},{"key":"28_CR88","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1117634","volume":"310","author":"M Platten","year":"2005","unstructured":"Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310:850\u2013855","journal-title":"Science"},{"key":"28_CR89","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJ Schiepers","year":"2005","unstructured":"Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201\u2013217","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"28_CR90","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","volume":"105","author":"R Owe-Young","year":"2008","unstructured":"Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, Walker D, Armati PJ, Crowe SM, Brew BJ (2008) Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem 105:1346\u20131357","journal-title":"J Neurochem"},{"key":"28_CR91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0893-133X(97)00198-X","volume":"19","author":"LL Carpenter","year":"1998","unstructured":"Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH, Heninger GR, McDougle CJ (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26\u201335","journal-title":"Neuropsychopharmacology"},{"key":"28_CR92","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3181\/00379727-113-28451","volume":"113","author":"WJ Culley","year":"1963","unstructured":"Culley WJ, Saunders RN, Mertz ET, Jolly DH (1963) Effect of a tryptophan deficient diet on brain serotonin and plasma tryptophan level. Proc Soc Exp Biol Med 113:645\u2013648","journal-title":"Proc Soc Exp Biol Med"},{"key":"28_CR93","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/archpsyc.1990.01810170011002","volume":"47","author":"PL Delgado","year":"1990","unstructured":"Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411\u2013418","journal-title":"Arch Gen Psychiatry"},{"key":"28_CR94","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/jnr.21325","volume":"85","author":"S Tilleux","year":"2007","unstructured":"Tilleux S, Hermans E (2007) Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85:2059\u20132070","journal-title":"J Neurosci Res"},{"key":"28_CR95","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62:63\u201377","journal-title":"Neuropharmacology"},{"key":"28_CR96","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","volume":"35","author":"PA Zunszain","year":"2011","unstructured":"Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM (2011) Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 35:722\u2013729","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"28_CR97","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/eci.09.56","volume":"5","author":"BP Chapman","year":"2009","unstructured":"Chapman BP, Moynihan J (2009) The brain-skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Rev Clin Immunol 5:623\u2013627","journal-title":"Expert Rev Clin Immunol"},{"key":"28_CR98","first-page":"221","volume":"145","author":"J Moynihan","year":"2010","unstructured":"Moynihan J, Rieder E, Tausk F (2010) Psychoneuroimmunology: the example of psoriasis. G Ital Dermatol Venereol 145:221\u2013228","journal-title":"G Ital Dermatol Venereol"},{"key":"28_CR99","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1192\/bjp.143.1.51","volume":"143","author":"JE Hughes","year":"1983","unstructured":"Hughes JE, Barraclough BM, Hamblin LG, White JE (1983) Psychiatric symptoms in dermatology patients. Br J Psychiatry 143:51\u201354","journal-title":"Br J Psychiatry"},{"key":"28_CR100","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.det.2005.05.022","volume":"23","author":"DG Fortune","year":"2005","unstructured":"Fortune DG, Richards HL, Griffiths CE (2005) Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 23:681\u2013694","journal-title":"Dermatol Clin"},{"key":"28_CR101","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1067\/mjd.2001.110876","volume":"44","author":"L Naldi","year":"2001","unstructured":"Naldi L, Peli L, Parazzini F, Carrel CF (2001) Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol 44:433\u2013438","journal-title":"J Am Acad Dermatol"},{"key":"28_CR102","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1348\/014466502163949","volume":"41","author":"DG Fortune","year":"2002","unstructured":"Fortune DG, Richards HL, Griffiths CE, Main CJ (2002) Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 41:157\u2013174","journal-title":"Br J Clin Psychol"},{"key":"28_CR103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1348\/014466504772812977","volume":"43","author":"DG Fortune","year":"2004","unstructured":"Fortune DG, Richards HL, Griffiths CE, Main CJ (2004) Targeting cognitive-behaviour therapy to patients\u2019 implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 43:65\u201382","journal-title":"Br J Clin Psychol"},{"key":"28_CR104","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0190-9622(96)90280-7","volume":"34","author":"R Zachariae","year":"1996","unstructured":"Zachariae R, Oster H, Bjerring P, Kragballe K (1996) Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol 34:1008\u20131015","journal-title":"J Am Acad Dermatol"},{"key":"28_CR105","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00006842-199809000-00020","volume":"60","author":"J Kabat-Zinn","year":"1998","unstructured":"Kabat-Zinn J, Wheeler E, Light T, Skillings A, Scharf MJ, Cropley TG, Hosmer D, Bernhard JD (1998) Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 60:625\u2013632","journal-title":"Psychosom Med"},{"key":"28_CR106","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/jdv.12909","volume":"29","author":"P Fleming","year":"2015","unstructured":"Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B, Gulliver WP (2015) Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol 29:1063\u20131070","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"28_CR107","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","volume":"62","author":"A Menter","year":"2010","unstructured":"Menter A, Augustin M, Signorovitch J, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani P (2010) The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol 62:812\u2013818","journal-title":"J Am Acad Dermatol"},{"key":"28_CR108","doi-asserted-by":"publisher","first-page":"493012","DOI":"10.1155\/2015\/493012","volume":"2015","author":"BR de Mattos","year":"2015","unstructured":"de Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM, Simioni PU (2015) Inflammatory bowel disease: an overview of immune mechanisms and biological treatments. Mediators Inflamm 2015:493012","journal-title":"Mediators Inflamm"},{"key":"28_CR109","first-page":"241","volume":"59","author":"B Bonaz","year":"2013","unstructured":"Bonaz B (2013) Inflammatory bowel diseases: a dysfunction of brain-gut interactions? Minerva Gastroenterol Dietol 59:241\u2013259","journal-title":"Minerva Gastroenterol Dietol"},{"key":"28_CR110","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","volume":"144","author":"BL Bonaz","year":"2013","unstructured":"Bonaz BL, Bernstein CN (2013) Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144:36\u201349","journal-title":"Gastroenterology"},{"key":"28_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cgh.2012.08.032","volume":"11","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, Khalili H, Pan A, Higuchi LM, de Silva P, Richter JM, Fuchs CS, Chan AT (2013) Association between depressive symptoms and incidence of Crohn\u2019s disease and ulcerative colitis: results from the Nurses\u2019 Health Study. Clin Gastroenterol Hepatol 11:57\u201362","journal-title":"Clin Gastroenterol Hepatol"},{"key":"28_CR112","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/ibd.21846","volume":"18","author":"JR Goodhand","year":"2012","unstructured":"Goodhand JR, Greig FI, Koodun Y, McDermott A, Wahed M, Langmead L, Rampton DS (2012) Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis 18:1232\u20131239","journal-title":"Inflamm Bowel Dis"},{"key":"28_CR113","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7812\/TPP\/14-120","volume":"19","author":"D Cawthorpe","year":"2015","unstructured":"Cawthorpe D, Davidson M (2015) Temporal comorbidity of mental disorder and ulcerative colitis. Perm J 19:52\u201357","journal-title":"Perm J"},{"key":"28_CR114","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-230X-14-77","volume":"14","author":"II Vlachos","year":"2014","unstructured":"Vlachos II, Barbatis C, Tsopanomichalou M, Abou-Assabeh L, Goumas K, Ginieri-Coccossis M, Economou M, Papadimitriou GN, Patsouris E, Nicolopoulou-Stamati P (2014) Correlation between depression, anxiety, and polymorphonuclear cells\u2019 resilience in ulcerative colitis: the mediating role of heat shock protein 70. BMC Gastroenterol 14:77","journal-title":"BMC Gastroenterol"},{"key":"28_CR115","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1023\/B:DDAS.0000020509.23162.cc","volume":"49","author":"HE Mardini","year":"2004","unstructured":"Mardini HE, Kip KE, Wilson JW (2004) Crohn\u2019s disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 49:492\u2013497","journal-title":"Dig Dis Sci"},{"key":"28_CR116","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/01.PSY.0000106907.24881.F2","volume":"66","author":"C Mittermaier","year":"2004","unstructured":"Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, Tillinger W, Gangl A, Moser G (2004) Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66:79\u201384","journal-title":"Psychosom Med"},{"key":"28_CR117","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219","journal-title":"N Engl J Med"},{"key":"28_CR118","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/070674370404900208","volume":"49","author":"P Waraich","year":"2004","unstructured":"Waraich P, Goldner EM, Somers JM, Hsu L (2004) Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 49:124\u2013138","journal-title":"Can J Psychiatry"},{"key":"28_CR119","first-page":"1013","volume":"32","author":"DC Ang","year":"2005","unstructured":"Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013\u20131019","journal-title":"J Rheumatol"},{"key":"28_CR120","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/rheumatology\/keq043","volume":"49","author":"D van Hoogmoed","year":"2010","unstructured":"van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P (2010) Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 49:1294\u20131302","journal-title":"Rheumatology (Oxford)"},{"key":"28_CR121","first-page":"952","volume":"30","author":"T Mikuls","year":"2003","unstructured":"Mikuls T, Saag K, Criswell L, Merlino L, Cerhan JR (2003) Health related quality of life in women with elderly onset rheumatoid arthritis. J Rheumatol 30:952\u2013957","journal-title":"J Rheumatol"},{"key":"28_CR122","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.24428","volume":"61","author":"F Wolfe","year":"2009","unstructured":"Wolfe F, Michaud K (2009) Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum 61:667\u2013673","journal-title":"Arthritis Rheum"},{"key":"28_CR123","doi-asserted-by":"publisher","first-page":"e000670","DOI":"10.1136\/rmdopen-2018-000670","volume":"4","author":"IA Vallerand","year":"2018","unstructured":"Vallerand IA, Lewinson RT, Frolkis AD, Lowerison MW, Kaplan GG, Swain MG, Bulloch AGM, Patten SB, Barnabe C (2018) Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study. RMD Open 4:e000670","journal-title":"RMD Open"},{"key":"28_CR124","volume":"2012","author":"TJ Braley","year":"2012","unstructured":"Braley TJ, Chervin RD, Segal BM (2012) Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography. Mult Scler Int 2012:673936","journal-title":"Mult Scler Int"},{"key":"28_CR125","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1212\/01.WNL.0000095964.34294.B4","volume":"61","author":"SB Patten","year":"2003","unstructured":"Patten SB, Beck CA, Williams JV, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61:1524\u20131527","journal-title":"Neurology"},{"key":"28_CR126","first-page":"271321","volume":"2011","author":"M Tarrants","year":"2011","unstructured":"Tarrants M, Oleen-Burkey M, Castelli-Haley J, Lage MJ (2011) The impact of comorbid depression on adherence to therapy for multiple sclerosis. Mult Scler Int 2011:271321","journal-title":"Mult Scler Int"},{"key":"28_CR127","first-page":"275","volume":"28","author":"SB Patten","year":"2013","unstructured":"Patten SB, Williams JV, Lavorato DH, Koch M, Metz LM (2013) Depression as a predictor of occupational transition in a multiple sclerosis cohort. Funct Neurol 28:275\u2013280","journal-title":"Funct Neurol"},{"key":"28_CR128","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/bmj.315.7110.691","volume":"315","author":"A Feinstein","year":"1997","unstructured":"Feinstein A (1997) Multiple sclerosis, depression, and suicide. Clinicians should pay more attention to psychopathology. BMJ 315:691\u2013692","journal-title":"BMJ"},{"key":"28_CR129","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/WNL.59.5.674","volume":"59","author":"A Feinstein","year":"2002","unstructured":"Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674\u2013678","journal-title":"Neurology"},{"key":"28_CR130","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jpsychores.2012.09.011","volume":"73","author":"M Pompili","year":"2012","unstructured":"Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G, Amore M, Girardi P (2012) Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res 73:411\u2013417","journal-title":"J Psychosom Res"},{"key":"28_CR131","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70:31\u201341","journal-title":"JAMA Psychiat"},{"key":"28_CR132","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2009.09.014","volume":"63","author":"RG Langley","year":"2010","unstructured":"Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB (2010) Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol 63:457\u2013465","journal-title":"J Am Acad Dermatol"},{"key":"28_CR133","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mehy.2010.08.021","volume":"76","author":"E Brietzke","year":"2011","unstructured":"Brietzke E, Scheinberg M, Lafer B (2011) Therapeutic potential of interleukin-6 antagonism in bipolar disorder. Med Hypotheses 76:21\u201323","journal-title":"Med Hypotheses"},{"issue":"1017","key":"28_CR134","first-page":"e1011","volume":"126","author":"RL Iyengar","year":"2013","unstructured":"Iyengar RL, Gandhi S, Aneja A, Thorpe K, Razzouk L, Greenberg J, Mosovich S, Farkouh ME (2013) NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med 126(1017):e1011\u2013e1018","journal-title":"Am J Med"},{"key":"28_CR135","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O Kohler","year":"2014","unstructured":"Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, Krogh J (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat 71:1381\u20131391","journal-title":"JAMA Psychiat"},{"key":"28_CR136","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1073\/pnas.1104836108","volume":"108","author":"JL Warner-Schmidt","year":"2011","unstructured":"Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011) Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A 108:9262\u20139267","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28_CR137","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s13063-018-2829-7","volume":"19","author":"C Fourrier","year":"2018","unstructured":"Fourrier C, Sampson E, Mills NT, Baune BT (2018) Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials 19:447","journal-title":"Trials"},{"key":"28_CR138","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","volume":"762","author":"A Sluzewska","year":"1995","unstructured":"Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762:474\u2013476","journal-title":"Ann N Y Acad Sci"},{"key":"28_CR139","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.psychres.2009.04.013","volume":"178","author":"S Jazayeri","year":"2010","unstructured":"Jazayeri S, Keshavarz SA, Tehrani-Doost M, Djalali M, Hosseini M, Amini H, Chamari M, Djazayery A (2010) Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Psychiatry Res 178:112\u2013115","journal-title":"Psychiatry Res"},{"key":"28_CR140","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2003.11.006","volume":"4","author":"M Kubera","year":"2004","unstructured":"Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, Budziszewska B, Maes M (2004) Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 4:185\u2013192","journal-title":"Int Immunopharmacol"},{"key":"28_CR141","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 170:1134\u20131142","journal-title":"Am J Psychiatry"},{"key":"28_CR142","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cns.12104","volume":"19","author":"M De Kock","year":"2013","unstructured":"De Kock M, Loix S, Lavand\u2019homme P (2013) Ketamine and peripheral inflammation. CNS Neurosci Ther 19:403\u2013410","journal-title":"CNS Neurosci Ther"},{"key":"28_CR143","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297\u2013306","journal-title":"Depress Anxiety"},{"key":"28_CR144","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732\u2013741","journal-title":"Biol Psychiatry"},{"key":"28_CR145","unstructured":"Raison CL, Felger JC, Miller AH (2013) Inflammation and treatment resistance in major depression: the perfect storm. Psychiatr Times 30"},{"key":"28_CR146","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","volume":"32","author":"T Eller","year":"2008","unstructured":"Eller T, Vasar V, Shlik J, Maron E (2008) Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuro Psychopharmacol Biol Psychiatry 32:445\u2013450","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"28_CR147","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22\u201334","journal-title":"Nat Rev Immunol"},{"key":"28_CR148","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2014.06.032","volume":"1617","author":"FE Lotrich","year":"2015","unstructured":"Lotrich FE (2015) Inflammatory cytokine-associated depression. Brain Res 1617:113\u2013125","journal-title":"Brain Res"},{"key":"28_CR149","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2147\/NDT.S114542","volume":"13","author":"R Strawbridge","year":"2017","unstructured":"Strawbridge R, Young AH, Cleare AJ (2017) Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat 13:1245\u20131262","journal-title":"Neuropsychiatr Dis Treat"},{"key":"28_CR150","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-015-0471-9","volume":"13","author":"M Postal","year":"2016","unstructured":"Postal M, Lapa AT, Sinicato NA, de Oliveira Peli\u00e7ari K, Peres FA, Costallat LTL, Fernandes PT, Marini R, Appenzeller S (2016) Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus. J Neuroinflammation 13:5","journal-title":"J Neuroinflammation"},{"key":"28_CR151","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3892\/br.2016.807","volume":"6","author":"RK Farooq","year":"2017","unstructured":"Farooq RK, Asghar K, Kanwal S, Zulqernain A (2017) Role of inflammatory cytokines in depression: focus on interleukin-1beta. Biomed Rep 6:15\u201320","journal-title":"Biomed Rep"},{"key":"28_CR152","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171\u2013186","journal-title":"Psychosom Med"},{"key":"28_CR153","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"28_CR154","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ (2015) Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 25:1532\u20131543","journal-title":"Eur Neuropsychopharmacol"},{"key":"28_CR155","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:2452\u20132459","journal-title":"Neuropsychopharmacology"},{"key":"28_CR156","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","volume":"21","author":"N Quan","year":"2007","unstructured":"Quan N, Banks WA (2007) Brain-immune communication pathways. Brain Behav Immun 21:727\u2013735","journal-title":"Brain Behav Immun"},{"key":"28_CR157","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nri1964","volume":"6","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, Bonecchi R, Locati M (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6:907","journal-title":"Nat Rev Immunol"},{"key":"28_CR158","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610\u2013621","journal-title":"N Engl J Med"},{"key":"28_CR159","first-page":"357","volume":"9","author":"MJ Stuart","year":"2015","unstructured":"Stuart MJ, Singhal G, Baune BT (2015) Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front Cell Neurosci 9:357","journal-title":"Front Cell Neurosci"},{"key":"28_CR160","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","volume":"42","author":"MJ Stuart","year":"2014","unstructured":"Stuart MJ, Baune BT (2014) Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci Biobehav Rev 42:93\u2013115","journal-title":"Neurosci Biobehav Rev"},{"key":"28_CR161","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12035-007-0036-8","volume":"36","author":"AH de Haas","year":"2007","unstructured":"de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP (2007) Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol 36:137\u2013151","journal-title":"Mol Neurobiol"},{"key":"28_CR162","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","volume":"126","author":"Y-J Gao","year":"2010","unstructured":"Gao Y-J, Ji R-R (2010) Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 126:56\u201368","journal-title":"Pharmacol Ther"},{"key":"28_CR163","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/cne.20598","volume":"489","author":"G Banisadr","year":"2005","unstructured":"Banisadr G, Gosselin RD, Mechighel P, Kitabgi P, Rostene W, Parsadaniantz SM (2005) Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1\/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 489:275\u2013292","journal-title":"J Comp Neurol"},{"key":"28_CR164","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1471-4159.2010.07121.x","volume":"116","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Tang H, Liu J, Dong J, Xiong H (2011) Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem 116:406\u2013414","journal-title":"J Neurochem"},{"key":"28_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/srep15862","volume":"5","author":"E Marciniak","year":"2015","unstructured":"Marciniak E, Faivre E, Dutar P, Alves Pires C, Demeyer D, Caillierez R, Laloux C, Buee L, Blum D, Humez S (2015) The Chemokine MIP-1alpha\/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory. Sci Rep 5:15862","journal-title":"Sci Rep"},{"key":"28_CR166","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1677\/JME-06-0035","volume":"38","author":"C Callewaere","year":"2007","unstructured":"Callewaere C, Banisadr G, Rostene W, Parsadaniantz SM (2007) Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J Mol Endocrinol 38:355\u2013363","journal-title":"J Mol Endocrinol"},{"key":"28_CR167","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tins.2012.06.003","volume":"35","author":"M Li","year":"2012","unstructured":"Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD (2012) Chemokine CXCL12 in neurodegenerative diseases: a S.O.S signal for stem cell-based repair. Trends Neurosci 35:619\u2013628","journal-title":"Trends Neurosci"},{"key":"28_CR168","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneuroim.2008.04.012","volume":"198","author":"K Biber","year":"2008","unstructured":"Biber K, Vinet J, Boddeke HWGM (2008) Neuron-microglia signaling: chemokines as versatile messengers. J Neuroimmunol 198:69\u201374","journal-title":"J Neuroimmunol"},{"key":"28_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2016.02.006","volume":"68","author":"HA Eyre","year":"2016","unstructured":"Eyre HA, Air T, Pradhan A, Johnston J, Lavretsky H, Stuart MJ, Baune BT (2016) A meta-analysis of chemokines in major depression. Prog Neuro Psychopharmacol Biol Psychiatry 68:1\u20138","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"28_CR170","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA Kohler","year":"2017","unstructured":"Kohler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanctot KL, Carvalho AF (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135:373\u2013387","journal-title":"Acta Psychiatr Scand"},{"key":"28_CR171","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","volume":"35","author":"SM Lehto","year":"2010","unstructured":"Lehto SM, Niskanen L, Herzig KH, Tolmunen T, Huotari A, Viinamaki H, Koivumaa-Honkanen H, Honkalampi K, Ruotsalainen H, Hintikka J (2010) Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 35:226\u2013232","journal-title":"Psychoneuroendocrinology"},{"key":"28_CR172","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.psyneuen.2012.02.006","volume":"37","author":"BT Baune","year":"2012","unstructured":"Baune BT, Smith E, Reppermund S, Air T, Samaras K, Lux O, Brodaty H, Sachdev P, Trollor JN (2012) Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 37:1521\u20131530","journal-title":"Psychoneuroendocrinology"},{"key":"28_CR173","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/mp.2017.205","volume":"23","author":"SP Leighton","year":"2017","unstructured":"Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J (2017) Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry 23:48","journal-title":"Mol Psychiatry"},{"issue":"34","key":"28_CR174","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1590\/S1516-44462012000100013","volume":"1999","author":"R Grassi-Oliveira","year":"2012","unstructured":"Grassi-Oliveira R, Brieztke E, Teixeira A, Pezzi JC, Zanini M, Lopes RP, Bauer ME (2012) Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Revista Brasileira de Psiquiatria 1999(34):71\u201375","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"28_CR175","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/09511920410001713484","volume":"13","author":"RA Merendino","year":"2004","unstructured":"Merendino RA, Di Pasquale G, De Luca F, Di Pasquale L, Ferlazzo E, Martino G, Palumbo MC, Morabito F, Gangemi S (2004) Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression. Mediators Inflamm 13:205\u2013207","journal-title":"Mediators Inflamm"},{"key":"28_CR176","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0269881108091077","volume":"23","author":"T Eller","year":"2009","unstructured":"Eller T, Vasar V, Shlik J, Maron E (2009) Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder. J Psychopharmacol 23:854\u2013858","journal-title":"J Psychopharmacol"},{"key":"28_CR177","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11597","volume":"79","author":"JL Kruse","year":"2018","unstructured":"Kruse JL, Congdon E, Olmstead R, Njau S, Breen EC, Narr KL, Espinoza R, Irwin MR (2018) Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression. J Clin Psychiatry 79:pii: 17m11597","journal-title":"J Clin Psychiatry"},{"key":"28_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.31","volume":"7","author":"DD Kiraly","year":"2017","unstructured":"Kiraly DD, Horn SR, Van Dam NT, Costi S, Schwartz J, Kim-Schulze S, Patel M, Hodes GE, Russo SJ, Merad M, Iosifescu DV, Charney DS, Murrough JW (2017) Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl Psychiatry 7:e1065","journal-title":"Transl Psychiatry"},{"key":"28_CR179","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0065-2423(09)48005-3","volume":"48","author":"CM Eklund","year":"2009","unstructured":"Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48:111\u2013136","journal-title":"Adv Clin Chem"},{"key":"28_CR180","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Investig 111:1805\u20131812","journal-title":"J Clin Investig"},{"key":"28_CR181","first-page":"439","volume":"29","author":"SS Bassuk","year":"2004","unstructured":"Bassuk SS, Rifai N, Ridker PM (2004) High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29:439\u2013493","journal-title":"Curr Probl Cardiol"},{"key":"28_CR182","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499\u2013511","journal-title":"Circulation"},{"key":"28_CR183","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","volume":"70","author":"MK Wium-Andersen","year":"2013","unstructured":"Wium-Andersen MK, Orsted DD, Nielsen SF, Nordestgaard BG (2013) Elevated C-reactive protein levels, psychological distress, and depression in 73131 individuals. JAMA Psychiat 70:176\u2013184","journal-title":"JAMA Psychiat"},{"key":"28_CR184","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.biopsych.2006.02.016","volume":"60","author":"T Liukkonen","year":"2006","unstructured":"Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M (2006) The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 60:825\u2013830","journal-title":"Biol Psychiatry"},{"key":"28_CR185","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/01.PSY.0000041542.29808.01","volume":"65","author":"M Danner","year":"2003","unstructured":"Danner M, Kasl SV, Abramson JL, Vaccarino V (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65:347\u2013356","journal-title":"Psychosom Med"},{"key":"28_CR186","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/PSY.0b013e31819e333a","volume":"71","author":"M Elovainio","year":"2009","unstructured":"Elovainio M, Aalto AM, Kivimaki M, Pirkola S, Sundvall J, Lonnqvist J, Reunanen A (2009) Depression and C-reactive protein: population-based Health 2000 study. Psychosom Med 71:423\u2013430","journal-title":"Psychosom Med"},{"key":"28_CR187","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1017\/S0033291710000887","volume":"41","author":"O Bjerkeset","year":"2011","unstructured":"Bjerkeset O, Romild U, Smith GD, Hveem K (2011) The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study. Psychol Med 41:345\u2013352","journal-title":"Psychol Med"},{"key":"28_CR188","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.bbi.2018.08.009","volume":"73","author":"CL Raison","year":"2018","unstructured":"Raison CL, Pikalov A, Siu C, Tsai J, Koblan K, Loebel A (2018) C-reactive protein and response to lurasidone in patients with bipolar depression. Brain, behavior, and immunity 73:717","journal-title":"Brain, behavior, and immunity"},{"key":"28_CR189","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4088\/JCP.15m10267","volume":"77","author":"MS Cepeda","year":"2016","unstructured":"Cepeda MS, Stang P, Makadia R (2016) Depression is associated with high levels of c-reactive protein and low levels of fractional exhaled nitric oxide: results from the 2007-2012 national health and nutrition examination surveys. J Clin Psychiatry 77:1666\u20131671","journal-title":"J Clin Psychiatry"},{"key":"28_CR190","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimaki M (2015) Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215","journal-title":"Brain Behav Immun"},{"key":"28_CR191","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbi.2012.11.012","volume":"28","author":"A Wieck","year":"2013","unstructured":"Wieck A, Andersen SL, Brenhouse HC (2013) Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: relationship to cortical NMDA receptor expression. Brain Behav Immun 28:218\u2013226","journal-title":"Brain Behav Immun"},{"key":"28_CR192","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.lfs.2012.09.023","volume":"91","author":"O Mutlu","year":"2012","unstructured":"Mutlu O, Gumuslu E, Ulak G, Celikyurt IK, Kokturk S, K\u0131r HM, Akar F, Erden F (2012) Effects of fluoxetine, tianeptine and olanzapine on unpredictable chronic mild stress-induced depression-like behavior in mice. Life Sci 91:1252\u20131262","journal-title":"Life Sci"},{"key":"28_CR193","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbi.2012.07.011","volume":"26","author":"ML Hanke","year":"2012","unstructured":"Hanke ML, Powell ND, Stiner LM, Bailey MT, Sheridan JF (2012) Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress. Brain Behav Immun 26:1150\u20131159","journal-title":"Brain Behav Immun"},{"key":"28_CR194","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.pnpbp.2010.05.019","volume":"34","author":"L Carboni","year":"2010","unstructured":"Carboni L, Becchi S, Piubelli C, Mallei A, Giambelli R, Razzoli M, Math\u00e9 AA, Popoli M, Domenici E (2010) Early-life stress and antidepressants modulate peripheral biomarkers in a gene\u2013environment rat model of depression. Prog Neuro Psychopharmacol Biol Psychiatry 34:1037\u20131048","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"28_CR195","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1523\/JNEUROSCI.3569-08.2009","volume":"29","author":"C Song","year":"2009","unstructured":"Song C, Zhang XY, Manku M (2009) Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 29:14\u201322","journal-title":"J Neurosci"},{"key":"28_CR196","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/7854_2010_108","volume":"7","author":"V Krishnan","year":"2011","unstructured":"Krishnan V, Nestler EJ (2011) Animal models of depression: molecular perspectives. Curr Top Behav Neurosci 7:121\u2013147","journal-title":"Curr Top Behav Neurosci"},{"key":"28_CR197","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1038\/tp.2014.140","volume":"5","author":"C Murgatroyd","year":"2015","unstructured":"Murgatroyd C, Quinn JP, Sharp HM, Pickles A, Hill J (2015) Effects of prenatal and postnatal depression, and maternal stroking, at the glucocorticoid receptor gene. Transl Psychiatry 5:e560","journal-title":"Transl Psychiatry"},{"key":"28_CR198","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1460-9568.2004.03592.x","volume":"20","author":"F Fumagalli","year":"2004","unstructured":"Fumagalli F, Bedogni F, Perez J, Racagni G, Riva MA (2004) Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 20:1348\u20131354","journal-title":"Eur J Neurosci"},{"key":"28_CR199","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1742-2094-9-71","volume":"9","author":"Y Diz-Chaves","year":"2012","unstructured":"Diz-Chaves Y, Pernia O, Carrero P, Garcia-Segura LM (2012) Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J Neuroinflammation 9:71","journal-title":"J Neuroinflammation"},{"key":"28_CR200","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2005.12.001","volume":"169","author":"JC Brenes Saenz","year":"2006","unstructured":"Brenes Saenz JC, Villagra OR, Fornaguera Trias J (2006) Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats. Behav Brain Res 169:57\u201365","journal-title":"Behav Brain Res"},{"key":"28_CR201","first-page":"Unit 8.10C","volume":"Chapter 8","author":"H Anisman","year":"2001","unstructured":"Anisman H, Merali Z (2001) Rodent models of depression: learned helplessness induced in mice. Curr Protoc Neurosci Chapter 8:Unit 8.10C","journal-title":"Curr Protoc Neurosci"},{"key":"28_CR202","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125892","volume":"10","author":"D Landgraf","year":"2015","unstructured":"Landgraf D, Long J, Der-Avakian A, Streets M, Welsh DK (2015) Dissociation of learned helplessness and fear conditioning in mice: a mouse model of depression. PLoS One 10:e0125892","journal-title":"PLoS One"},{"key":"28_CR203","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","volume":"6","author":"P Willner","year":"2017","unstructured":"Willner P (2017) The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress 6:78\u201393","journal-title":"Neurobiol Stress"},{"key":"28_CR204","first-page":"Unit 5.65","volume":"Chapter 5","author":"M Nollet","year":"2013","unstructured":"Nollet M, Le Guisquet AM, Belzung C (2013) Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol Chapter 5:Unit 5.65","journal-title":"Curr Protoc Pharmacol"},{"key":"28_CR205","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/932757","volume":"2014","author":"M Stepanichev","year":"2014","unstructured":"Stepanichev M, Dygalo NN, Grigoryan G, Shishkina GT, Gulyaeva N (2014) Rodent models of depression: neurotrophic and neuroinflammatory biomarkers. Biomed Res Int 2014:932757","journal-title":"Biomed Res Int"},{"key":"28_CR206","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nprot.2011.361","volume":"6","author":"SA Golden","year":"2011","unstructured":"Golden SA, Covington HE III, Berton O, Russo SJ (2011) A standardized protocol for repeated social defeat stress in mice. Nat Protoc 6:1183\u20131191","journal-title":"Nat Protoc"},{"key":"28_CR207","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw028","volume":"19","author":"JL Remus","year":"2016","unstructured":"Remus JL, Dantzer R (2016) Inflammation models of depression in rodents: relevance to psychotropic drug discovery. Int J Neuropsychopharmacol 19:pii: pyw028","journal-title":"Int J Neuropsychopharmacol"},{"key":"28_CR208","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ncl.2006.03.003","volume":"24","author":"R Dantzer","year":"2006","unstructured":"Dantzer R (2006) Cytokine, sickness behavior, and depression. Neurol Clin 24:441\u2013460","journal-title":"Neurol Clin"},{"key":"28_CR209","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511\u2013522","journal-title":"Mol Psychiatry"},{"key":"28_CR210","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1038\/s41386-018-0154-1","volume":"43","author":"G Laumet","year":"2018","unstructured":"Laumet G, Edralin JD, Chiang AC-A, Dantzer R, Heijnen CJ, Kavelaars A (2018) Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology 43:2597","journal-title":"Neuropsychopharmacology"},{"key":"28_CR211","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.mp.4002055","volume":"13","author":"I Goshen","year":"2008","unstructured":"Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R (2008) Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13:717\u2013728","journal-title":"Mol Psychiatry"},{"key":"28_CR212","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1073\/pnas.0910658107","volume":"107","author":"JW Koo","year":"2010","unstructured":"Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010) Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A 107:2669\u20132674","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28_CR213","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1038\/tp.2012.120","volume":"2","author":"SJ Sukoff Rizzo","year":"2012","unstructured":"Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, Brandon NJ (2012) Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2:e199","journal-title":"Transl Psychiatry"},{"key":"28_CR214","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP (2008) Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5:15","journal-title":"J Neuroinflammation"},{"key":"28_CR215","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1523\/JNEUROSCI.2394-15.2016","volume":"36","author":"DB McKim","year":"2016","unstructured":"McKim DB, Niraula A, Tarr AJ, Wohleb ES, Sheridan JF, Godbout JP (2016) Neuroinflammatory dynamics underlie memory impairments after repeated social defeat. J Neurosci 36:2590","journal-title":"J Neurosci"},{"key":"28_CR216","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0006-8993(03)02757-4","volume":"977","author":"R De La Garza II","year":"2003","unstructured":"De La Garza R II, Asnis GM (2003) The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus. Brain Res 977:70\u201379","journal-title":"Brain Res"},{"key":"28_CR217","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbr.2015.07.015","volume":"293","author":"CW Fischer","year":"2015","unstructured":"Fischer CW, Eskelund A, Budac DP, Tillmann S, Liebenberg N, Elfving B, Wegener G (2015) Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats. Behav Brain Res 293:166\u2013172","journal-title":"Behav Brain Res"},{"key":"28_CR218","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/bcpt.12037","volume":"112","author":"A Karson","year":"2013","unstructured":"Karson A, Demirtas T, Bayramgurler D, Balci F, Utkan T (2013) Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin Pharmacol Toxicol 112:335\u2013340","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"28_CR219","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u2217D report. Am J Psychiatry 163:1905\u20131917","journal-title":"Am J Psychiatry"}],"container-title":["Methods in Molecular Biology","Psychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9554-7_28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:06:30Z","timestamp":1649955990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-9554-7_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493995530","9781493995547"],"references-count":219,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9554-7_28","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"5 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}